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INTRODUCTION 
     Heart tumors are rare primary tumors with benign 
heart tumors (BHTs) accounting for a majority of 
these tumors.1 BHTs have several subtypes and differ 
by age.1,2 Pediatric cases tend to be either 
rhabdomyomas or fibromas.1,3,4 In adults, the most 
common BHT is left atrial myxoma.1-3  
     Symptoms of these tumors are dependent on the 
size and location of tumor.2,3 In approximately a third 
of cases, the tumor has non-specific cardiac symptoms 
include dyspnea, syncope and arrhythmias.1,5 
Furthermore, BHTs have the potential to mimic other 
cardiac conditions by causing embolisms leading to 
cerebrovascular events or heart failure depending on 
tumor size and location.1,2,5 The mimicry of these 
tumors and non-specific symptoms can cause 
diagnosis to be difficult. Once these tumors are 
diagnosed, treatment is straightforward. Most often 
the tumor is resected in adults, unless surgery is 
contraindicated by underlying health conditions.2,3 In 
pediatric cases, resection of the tumor is possible but 
it may not be necessary because rhabdomyomas tend 
to decrease in size over time.4 Even with all this 
clinical information, data on the incidence of BHTs is 
limited. Knowledge of the incidence of BHTs is 
necessary to understand a potential source of cardiac 
disease that may be underdiagnosed. Currently 
available estimates stem from autopsy or surgery 
studies or from a single hospital or registry.6-10 Each of 
these presents a limited picture of the incidence. To 
alleviate this issue, we describe the incidence as well 
as demographic and clinical characteristics of all 






     Florida’s Center for Health Information and 
Transparency (FCHIT) provided these data for the 
analysis. Briefly, FCHIT is a branch of Florida’s 
Agency for Healthcare Administration that collects 
discharge data from all Floridian hospitals. We 
utilized discharge data for inpatient records collected 
from 1988 to 2012. In total, we reviewed over 55 
million discharge records for inpatient 
hospitalization. We reviewed each record’s principal 
ICD-9 diagnosis code. We looked for ICD-9 code 
212.7 to indicate if a patient was diagnosed with a 
BHT. To be consistent with the literature, we used 
212.7 as our main diagnostic code rather than 
searching for tumor specific codes since they were 
unavailable in these data. From these data, 
demographic and clinical data were obtained. Using 
only Florida residents, we estimated the yearly 
incidence of these BHTs. We used age adjustment to 
account for population differences using the 2000 
United States Census population counts. We 
standardized to the 2000 Census to be consistent with 
the literature and to have a constant standard 
population. All other descriptive statistics of the cases 
include a mix of Floridian and non-Floridian 
residents.  
     Basic demographic characteristics included: age 
at diagnosis, sex, and race. We collapsed race into 
three categories, white, black, and other minority 
races. Clinical characteristic included: admitting 
diagnosis (patients after 2005 only), admission type, 
length of stay, and status at discharge. We categorized 
admitting diagnosis based on the major organ systems 
of the body and using the ICD-9 broad diagnosis 
categories. We created five categories for status at  
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discharge including died in hospital, home or 
homecare, short and intermediate inpatient care, 
long-term inpatient care, and other. Other included 
other institutions such as hospice and psychiatric care 
etc. We performed all statistical analyses in SAS 
version 9.4 (SAS Institute, Cary N.C.). 
RESULTS 
     Overall, 1656 BHTs were diagnosed in Florida 
from 1988 to 2012. The incidence of these tumors 
increased (Figure 1
Figure 1.    Age- adjusted incidence rates of Benign Heart Tumors among hospital discharge data from Florida 
between 1988 and 2012.a
 
a Incidence rates are age-adjusted to the 2000 U.S. Census. 
The average yearly age-adjusted incidence of these 
tumors among Florida residents was 3.17 per one 
million (standard deviation (SD): 0.97). Women had 
twice as many of these tumors than men (Table 1). 
The average age-adjusted yearly incidence was 1.95 
per one million in men (SD: 0.66) while women had 
an average age-adjusted yearly incidence of 4.35 per 
one million people (SD: 1.45). Our sample was 
predominately white (84.8%) and female (69.2%). 
While the median age of onset was 63 years (Range: 
0 - 96).  Age of onset does appear to be bimodal with 
a peak occurring in children less than 10 years old 
and in adults in their sixties and seventies. Patients 
generally had a brief length of stay (<10 days) with 
46.9% of patients being discharged to home or self-
care. Approximately 2.5% of patients diagnosed with 
a BHT died in hospital. Of the patients whose 
admitting diagnosis were reported, a majority 
(55.9%) of them were admitted for either a benign or 
malignant tumor with another 16.6% were admitted 
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Table 1. Basic demographic and clinical characteristics of patients with a primary diagnosis of Benign Heart 
Tumors in Florida hospitals from 1988 to 2012.  
Characteristic n % 
Sex Female 1146 69.2% 
 Male 510 30.8% 
    
Age (in years) <10 53 3.2% 
 10-19 21 1.3% 
 20-29 31 1.9% 
 30-39 90 5.4% 
 40-49 197 11.9% 
 50-59 284 17.1% 
 60-69 433 26.1% 
 70-79 382 23.1% 
 80+ 165 10.0% 
    
Race a White 1279 85.2% 
 Black 159 10.6% 
 Other 64 4.3% 
 Missing 154  
    
Ethnicity Hispanic 158 10.6% 
 Non-Hispanic 1338 89.4% 
 Missing 160  
    
Resident status b Florida 1572 95.8% 
 Other 69 4.2% 
 Missing 15  
    
Admission type c Emergency 438 26.4% 
 Urgent 497 30.0% 
 Elective 711 42.9% 
 Newborn/Other 10 0.6% 
    
Discharge status d  Died 41 2.5% 
 Home or Homecare 1282 77.4% 
 Short & Intermediate Inpatient 158 9.5% 
 Long-term care 124 7.5% 
 Other 51 3.1% 
    
Length of stay (in days)  Median Range 
  7 0 - 201 
 
a Other category of race includes Asian, American Indian or Alaskan Native, and anyone reporting their race as 
other.  
b Other resident status includes anyone who stated their home state was not Florida. 
c Other admission type are those admission not covered by the other four categories. 
d Other status at discharge would include institutions not covered by the other four categories, including Hospice, 
psychiatric institutions, and Medicare institutions. 
 
DISCUSSION & CONCLUSION 
     In our study, the incidence of BHTs increased 
over time and women consistently had higher 
incidences of these tumors than men. The apparent 
rise in incidence may be attributed to better  
 
 
diagnostic tools as well as the increased awareness of 
these tumors. However, it is unclear if the rise in 
incidence is due to etiological factors or simply better 
diagnostic tools. Our incidence of BHTs differs from 
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previously reported incidences of these tumors. Cresti 
et al (2016) found incidence around 1.38 per 100,000 
people while Sigurjonsson et al (2011) found an 
incidence of 0.11 per 100,000 people.6,9 Both of these 
studies examined different rates in different 
populations, specifically primary benign and 
malignant tumors in a European community from 
1998 to 2010 and only cardiac myxomas in Europe, 
respectively.6,9 Additionally, the timing of the Cresti 
et al, (2016) does not match our study as we include a 
longer time period.6,9 It is possible that during these 
additional years these tumors were underdiagnosed.. 
The timing of between Sigurjonsson et al, (2011) and 
our study does match more closely but the standard 
population for age-adjusted are vastly different 
(world standard population versus the U.S. 
population). However, these differences likely do not 
account for the entire disparity between the incidence 
rates. Another U.S. based study provides a closer 
estimate of 0.63 per million but this study only 
evaluate primary malignant tumors.7 Primary 
malignant tumors only account for a small percentage 
of tumors so our estimated incidence is closer to what 
we would expect based on malignant tumor data.1 
Even so this does account for the apparent disparity 
in cardiac tumors between U.S. and European 
populations. 
     Based on our analysis these tumors are ill defined. 
While a majority were patients admitting diagnoses 
were benign or malignant tumors, we believe this 
may represent an error in large number of cases. 
BHTs are not apparent unless the patient has 
previously undergone a diagnostic procedure and the 
tumor had previously been discovered. Based on this 
it is possible that the admitting diagnosis was not 
defined, and the healthcare provider simply imputed 
the final diagnosis. However, over one sixth of the 
patients were admitted for a cardiac condition and 
almost a quarter were admitted for an ill-defined 
symptom.  
     The apparent 2 to 1 ratio of BHTs in women to 
men is interesting but not usual and is consistent with 
previous findings.3 It is currently unclear why a sex 
difference exists for BHTs. The primary population 
affected by BHTs in our study were over the age of 
40, white and non-Hispanic. Additionally, while a 
quarter of patients with BHTs were emergency 
admissions and less than one third were urgent 
admissions, most patients survived with limited 
hospital stays. 
     While we have discharge records from inpatient 
hospitalizations, these do not describe the entire 
clinical picture. We do not have pathological reports 
which would confirm these diagnoses. However, 
these tumors are extremely rare, and it is unlikely that 
they would misdiagnosed or miscoded. Future studies 
should include pathological reports to describe the 
incidence of BHTs by type. Another potential bias is 
the recurrence of these tumors. Recurrence has been 
reported in less than 5% of patients.2 With this 
recurrence rate it is unlikely that it would have a 
meaningful impact on the incidence of these tumors. 
Furthermore, both limitations would cause the 
incidence to appear higher than it is which would 
widen the disparity between our report and the 
European reports if these cases were identified. 
Additionally, we are confident in our results as they 
are similar in magnitude to reported malignant heart 
tumors in the US.7 Another potential limitation is the 
possibility of multiple visits per patient. However, 
because once these tumors are found they are readily 
removed it is unlikely that individuals would have 
more than one visit. Furthermore, if patients had 
more than one visit this would bolster our estimated 
incidence and removal of these cases would further 
separate our results from studies in Europe. 
Therefore, it is unlikely that there were multiple 
repeated visits for each patient. 
     Benign heart tumors are rare tumors that can 
mimic cardiac conditions and can lead to disability 
and death. We described the increasing incidence of 
these tumors utilizing hospital discharge records 
which may reflect increased awareness and better 
diagnostic tools. The incidence described here is 
similar in magnitude to other US reports but differs 
from European reports. We believe this is due to 
inherent differences in study design and diagnostic 
procedures. Regardless, even with the incidence of 
these tumors in question, the tumor etiology is 
unknown and requires case-control studies to 
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